Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

21 Sep 2018 | 12:54 PM

1,600.05
-62.90 (-3.78%)

  • Outperforms Index

    30.82%

    Return (1Y)

    Beaten Nifty 500 by 24.18%

  • More Volatile

    1.38%

    Standard Deviation (1Y)

    Higher than Nifty 500 by 0.67%

  • Not so consistent

    6/12

    Months

    underperformed Nifty 500

  • AxisDirect View

    No View

52 Week High-Low

1,800

1,800.05

1,010

1,010.00

News & Announcements

  • Glaxosmithkline Pharmaceuticals fixes record date for bonus issue

    28 days ago

  • Glaxosmithkline Pharmaceuticals standalone net profit rises 235.31% in the June 2018 quarter

    57 days ago

  • Board of Glaxosmithkline Pharmaceuticals recommends bonus issue of 1:1

    58 days ago

  • Glaxosmithkline Pharmaceuticals announces cessation of directors

    58 days ago

Price vs Volume

Stock Trivia

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 7.28% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -11.1% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 44.47% since past 1 Year

  • Glaxosmithkline Pharma Ltd has the 3rd highest P/Bratio according to FY201803 data among stocks in Pharmaceuticals Sector

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...